IRIS Accounts Production v25.4.12.37 11785726 director 1.2.25 31.1.26 31.1.26 false true false false true false Ordinary Shares 1.00000 iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 11785726 2025-01-31 11785726 2026-01-31 11785726 2025-02-01 2026-01-31 11785726 2024-01-31 11785726 2024-02-01 2025-01-31 11785726 2025-01-31 11785726 ns15:EnglandWales 2025-02-01 2026-01-31 11785726 ns14:PoundSterling 2025-02-01 2026-01-31 11785726 ns10:Director1 2025-02-01 2026-01-31 11785726 ns10:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 11785726 ns10:SmallEntities 2025-02-01 2026-01-31 11785726 ns10:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 11785726 ns10:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 11785726 ns10:AbridgedAccounts 2025-02-01 2026-01-31 11785726 ns10:OrdinaryShareClass1 2025-02-01 2026-01-31 11785726 ns10:RegisteredOffice 2025-02-01 2026-01-31 11785726 ns5:CurrentFinancialInstruments 2026-01-31 11785726 ns5:CurrentFinancialInstruments 2025-01-31 11785726 ns5:ShareCapital 2026-01-31 11785726 ns5:ShareCapital 2025-01-31 11785726 ns5:RetainedEarningsAccumulatedLosses 2026-01-31 11785726 ns5:RetainedEarningsAccumulatedLosses 2025-01-31 11785726 ns5:ComputerEquipment 2025-02-01 2026-01-31 11785726 ns10:OrdinaryShareClass1 2026-01-31

REGISTERED NUMBER: 11785726 (England and Wales)

APERTURE LABORATORIES LTD

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JANUARY 2026

APERTURE LABORATORIES LTD (REGISTERED NUMBER: 11785726) |

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2026

Page |

| Company Information | 1 |

| Abridged Statement of Financial Position | 2 |

| Notes to the Financial Statements | 4 |

| APERTURE LABORATORIES LTD |

COMPANY INFORMATION

FOR THE YEAR ENDED 31 JANUARY 2026

| DIRECTOR: | S J Irwin

| REGISTERED OFFICE: | 29 Cavendish Road

| St Albans

| Hertfordshire

| AL1 5EF

| REGISTERED NUMBER: | 11785726 (England and Wales)

| ACCOUNTANTS: | JKA Accountancy Limited

| Marlborough House

| 298 Regents Park Road

| London

| N3 2SZ

APERTURE LABORATORIES LTD (REGISTERED NUMBER: 11785726) |

ABRIDGED STATEMENT OF FINANCIAL POSITION

31 JANUARY 2026

| 2026 | 2025 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 8,447 |  | 6,013 |  |

CURRENT ASSETS

Stocks | 12,951 |  | 9,000 |  |

Debtors | 21,564 |  | - |  |

Cash at bank | 27,302 |  | 24,418 |  |

61,817 |  | 33,418 |  |

CREDITORS

Amounts falling due within one year | 18,428 |  | 28,501 |  |

NET CURRENT ASSETS | 43,389 |  | 4,917 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 51,836 |  | 10,930 |  |

CAPITAL AND RESERVES

Called up share capital | 5 | 1 |  | 1 |  |

Retained earnings | 51,835 |  | 10,929 |  |

SHAREHOLDERS' FUNDS | 51,836 |  | 10,930 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

APERTURE LABORATORIES LTD (REGISTERED NUMBER: 11785726) |

ABRIDGED STATEMENT OF FINANCIAL POSITION - continued

31 JANUARY 2026

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Statement of Financial Position for the year ended 31 January 2026 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 10 April 2026 and were signed by:

S J Irwin - Director

APERTURE LABORATORIES LTD (REGISTERED NUMBER: 11785726) |

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2026

1. | STATUTORY INFORMATION

| Aperture Laboratories Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Computer & Equipment | - | 33.33% on cost

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

APERTURE LABORATORIES LTD (REGISTERED NUMBER: 11785726) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 JANUARY 2026

2. | ACCOUNTING POLICIES - continued

| Debtors

| Basic financial assets, including trade and other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.

| Cash and cash equivalents

| Cash and cash equivalents are represented by cash in hand, deposits held at call with financial institutions, and other short-term highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

| Creditors

| Basic financial liabilities, including trade and other creditors, loans from third parties and loans from related parties, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective interest method, less any impairment.

| Financial instruments

| The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

| Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss.

| Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 1 (2025 - 1 ) .

APERTURE LABORATORIES LTD (REGISTERED NUMBER: 11785726) |

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 31 JANUARY 2026

4. | TANGIBLE FIXED ASSETS

| Totals

£ |

| COST

| At 1 February 2025 | 34,617 |  |

| Additions | 12,670 |  |

| At 31 January 2026 | 47,287 |  |

| DEPRECIATION

| At 1 February 2025 | 28,604 |  |

| Charge for year | 10,236 |  |

| At 31 January 2026 | 38,840 |  |

| NET BOOK VALUE

| At 31 January 2026 | 8,447 |  |

| At 31 January 2025 | 6,013 |  |

5. | CALLED UP SHARE CAPITAL

| Allotted, issued and fully paid:

| Number: | Class: | Nominal | 2026 | 2025 |

| value: | £ | £ |

| 1 | Ordinary Shares | £1 | 1 |  | 1 |  |

6. | ULTIMATE CONTROLLING PARTY

| The controlling party is S J Irwin.